Log in

CVE:KHRNKhiron Life Sciences Stock Price, Forecast & News

+0.02 (+2.82 %)
(As of 06/4/2020 05:18 AM ET)
Today's Range
Now: C$0.73
50-Day Range
MA: C$0.68
52-Week Range
Now: C$0.73
Volume214,116 shs
Average Volume457,702 shs
Market CapitalizationC$84.75 million
P/E RatioN/A
Dividend YieldN/A
Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. It also operates a network of health centers under the ILANS and Zerenia brands. In addition, the company develops CBD-based cosmeceutical products under the Kuida brand name. Khiron Life Sciences Corp. was founded in 2017 and is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.15 out of 5 stars

Industry, Sector and Symbol

Industry Drug Manufacturers—Specialty & Generic



Sales & Book Value

Annual SalesC$9.58 million
Cash FlowC$0.31 per share
Book ValueC$0.60 per share



Market CapC$84.75 million
Next Earnings DateN/A
OptionableNot Optionable

Receive KHRN News and Ratings via Email

Sign-up to receive the latest news and ratings for KHRN and its competitors with MarketBeat's FREE daily newsletter.

Khiron Life Sciences (CVE:KHRN) Frequently Asked Questions

How has Khiron Life Sciences' stock been impacted by COVID-19 (Coronavirus)?

Khiron Life Sciences' stock was trading at C$0.58 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, KHRN shares have increased by 25.9% and is now trading at C$0.73. View which stocks have been most impacted by Coronavirus.

What price target have analysts set for KHRN?

0 brokerages have issued 12 month target prices for Khiron Life Sciences' stock. Their forecasts range from C$5.00 to C$5.00. On average, they anticipate Khiron Life Sciences' stock price to reach C$5.00 in the next twelve months. This suggests a possible upside of 584.9% from the stock's current price. View analysts' price targets for Khiron Life Sciences.

Has Khiron Life Sciences been receiving favorable news coverage?

Media coverage about KHRN stock has been trending very negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Khiron Life Sciences earned a news impact score of -3.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutKhiron Life Sciences.

Who are some of Khiron Life Sciences' key competitors?

What other stocks do shareholders of Khiron Life Sciences own?

Who are Khiron Life Sciences' key executives?

Khiron Life Sciences' management team includes the following people:
  • Mr. Alvaro Francisco Torres, Founder, CEO & Interim Chairman (Age 40, Pay $425k)
  • Mr. Chris Naprawa, Pres (Age 50, Pay $1.69M)
  • Mr. Darren George Collins, Advisor (Age 36, Pay $205k)
  • Mr. Andres Galofre, Co-founder & VP of Bus. Devel.s (Age 38)
  • Ms. Wendy Kaufman CPA, Chief Financial Officer

What is Khiron Life Sciences' stock symbol?

Khiron Life Sciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KHRN."

How do I buy shares of Khiron Life Sciences?

Shares of KHRN and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Khiron Life Sciences' stock price today?

One share of KHRN stock can currently be purchased for approximately C$0.73.

How big of a company is Khiron Life Sciences?

Khiron Life Sciences has a market capitalization of C$84.75 million and generates C$9.58 million in revenue each year.

What is Khiron Life Sciences' official website?

The official website for Khiron Life Sciences is www.khiron.ca.

How can I contact Khiron Life Sciences?

The company can be reached via phone at 705-527-3564.

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.